Zobrazeno 1 - 10
of 37
pro vyhledávání: '"M. K Erofeeva"'
Autor:
M. K. Erofeeva, O. V. Gashinskaya, Zh. V. Buzitskaya, T. G. Zubkova, E. V. Shakhlanskaya, M. A. Stukova, D. A. Lioznov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 22, Iss 6, Pp 81-89 (2024)
Relevance. The emergence of a new SARS-COV-2 coronavirus in early 2020 radically changed the seasonal pattern of influenza and other acute respiratory infections worldwide. Along with a decrease in the frequency of RSV infection, the number of diagno
Externí odkaz:
https://doaj.org/article/a7a0b58f38e84d18ad13ad35b47eac06
Autor:
Zh. V. Buzitskaya, A. B. Popov, E. A. Romanovskaya-Romanko, M. V. Sergeeva, E. A. Varyushina, M. K. Erofeeva, M. A. Stukova, D. A. Lioznov
Publikováno v:
Медицинская иммунология, Vol 25, Iss 4, Pp 751-758 (2023)
Causing millions of cases worldwide every year, influenza is one of the most common respiratory infections. The effectiveness of influenza vaccination and the nature of the resulting immune response may vary depending on the vaccine composition and a
Externí odkaz:
https://doaj.org/article/c951c9d7c1764b95a6f9bc3af7ae1ba8
Autor:
M. K. Erofeeva, M. A. Stukova, E. V. Shakhlanskaya, Zh. V. Buzitskaya, V. L. Maksakova, T. I. Krainova, M. M. Pisareva, A. B. Popov, M. G. Pozdnjakova, D. A. Lioznov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 20, Iss 5, Pp 52-60 (2021)
Background. The vaccine is the best available instrument to prevent influenza and reduce the risks of major disease complications and mortality. The vaccine effectiveness during the influenza season depends on a number of factors: (1) a person vaccin
Externí odkaz:
https://doaj.org/article/4d131551320a41b09acad0828a2fa49f
Autor:
M. K. Erofeeva, M. A. Stukova, E. V. Shakhlanskaya, Zh. V. Buzitskaya, V. L. Maksakova, T. I. Krainova, T. M. Chirkina, M. M. Pisareva, D. A. Lioznov
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 19, Iss 5, Pp 76-83 (2020)
Background. The influenza vaccination coverage has steadily increased in the Russian Federation. The introduction of new domestic influenza vaccines into practice and the study of their effectiveness are of great importance for public health. However
Externí odkaz:
https://doaj.org/article/2f0348b52c514557baff4bf9779c6729
Publikováno v:
Журнал инфектологии, Vol 12, Iss 2, Pp 63-70 (2020)
Objective: comparative open-label randomized study of the safety and efficacy of the drugs Alpha-glutamyl-tryptophan + Ascorbic acid + Bendazole («Cytovir-3«) and Umifenovir for prophylactic influenza and acute respiratory viral infectionsin childr
Externí odkaz:
https://doaj.org/article/4df9e5a89ece4b688fd4ddf2423b6004
Autor:
T. V. Sologub, A. A. Shuldyakov, M. G. Romantsov, A. N. Zhekalov, S. V. Petlenko, M. K. Erofeeva, V. L. Maksakova, V. A. Isakov, V. V. Zarubaev, V. V. Gatsan, A. L. Kovalenko
Publikováno v:
Антибиотики и Химиотерапия, Vol 54, Iss 7-8, Pp 30-36 (2020)
Data on the study of the efficacy of the tablets of cycloferon, an early inductor of types 1 and 2 interferon, in the treatment of influenza and acute respiratory tract viral infections in adults are presented. The study enrolled 522 patients with mo
Externí odkaz:
https://doaj.org/article/23dfcaa303c545fda8739ee6a7f12384
Autor:
V. S. Smirnov, S. A. Saveliev, S. V. Petlenko, G. Redlich, M. K. Erofeeva, A. V. Lyovina, N. I. Zavialova
Publikováno v:
Инфекция и иммунитет, Vol 9, Iss 2, Pp 273-278 (2019)
Aim: To compare the safety and prophylactic efficacy of Cytovir-3 and Arbidol in an open-label randomized clinical trial in children at seasonal risk of infectious respiratory disease.Methods: This study was performed in the period preceding a season
Externí odkaz:
https://doaj.org/article/e2ce4ea93b604997b599b9daa9e85133
Autor:
I. V. Feldblyum, K. A. Subbotina, S. D. Novgorodova, G. M. Ignatev, M. Kh. Alyeva, M. K. Erofeeva, V. G. Orlovsky, I. A. Leneva, S. Ya. Melnikov, E. V. Kazakova, E. P. Nacharova, V. P. Trukhin
Publikováno v:
Журнал микробиологии, эпидемиологии и иммунобиологии, Vol 0, Iss 5, Pp 31-37 (2018)
Aim. The research was aimed at evaluating the reactogenicity, safety and immunogenicity of Flu-M inactivated split influenza vaccine. Materials and methods. The reactogenicity, safety and immunogenicity of the drug were studied in the course of a mul
Externí odkaz:
https://doaj.org/article/ec007c3713d04eba8b5496c38be7a79f
Autor:
D. A. Lioznov, S. M. Kharit, M. K. Erofeeva, T. G. Zubkova, O. V. Gorchakova, S. L. Nikolaenko
Publikováno v:
Эпидемиология и вакцинопрофилактика, Vol 17, Iss 3, Pp 57-62 (2018)
In this multicenter double blind randomized clinical study with parallel groups conducted with 612 healthy volunteers, domestic influenza quadrivalent inactivated subunit vaccine Grippol® Quadrivalent safety, tolerability and immunogenicity was eval
Externí odkaz:
https://doaj.org/article/71ef60e02c6e4ba48ee0fdd62eefa756
Autor:
I. V. Losev, S. A. Donina, G. D. Petukhova, D. A. Korenkov, M. K. Erofeeva, M. A. Stukova, L. G. Rudenko, A. N. Naykhin
Publikováno v:
Медицинская иммунология, Vol 19, Iss 4, Pp 375-386 (2017)
Over last years, a novel strategy for vaccination of people against potentially pandemic influenza A viruses is actively developed worldwide, i.e., a combined (prime-boost) vaccination. It provides amplification (boosting) of immune response for a va
Externí odkaz:
https://doaj.org/article/46686d32f94d403882ae8151ee8a087f